Ankara Yildirim Beyazit University Sports Sciences Laboratory
Ankara, 06000, Turkey (Türkiye)
NCT Number: NCT07567937
Wrestling is a weight-classified sport in which athletes frequently apply rapid weight loss (RWL) strategies prior to competition. While the performance-related consequences of RWL have been widely investigated, its combined effects with exercise on hematological parameters and immune cell profiles remain insufficiently understood. Therefore, this study aims to examine the effects of short-term weight loss and exercise on whole blood cell parameters and lymphocyte subsets in elite wrestlers.
Nine elite male wrestlers actively competing in the senior category (mean age: 22.90 ± 5.15 years; mean height: 1.75 m) voluntarily participated in this study. Athletes will achieve an average body mass reduction of 4.3% over a five-day period. Venous blood samples will be collected at 09:30 a.m. in a fasted state during two experimental phases: (1) Exercise-only phase, with blood sampling before and after exercise (BRWL1 and BRWL2); (2) Exercise plus weight loss phase, following the five-day weight loss period, with blood sampling before and after exercise (ARWL1 and ARWL2). Complete blood count parameters will be analyzed using an automated hematology analyzer, while lymphocyte subsets (CD3+, CD4+, CD8+, CD19+, CD16/56+) will be assessed by flow cytometry. Statistical analyses will be performed with a significance level set at p < 0.05.
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Not applicable
Ankara, 06000, Turkey (Türkiye)
See brief summary for study protocol details
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Standardized wrestling exercise session; pre- and post-exercise venous blood collected
Other names: Behavioral
5-day rapid weight loss protocol achieving average 4.3% body mass reduction
Time frame: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Change in total white blood cell (WBC) count measured from pre- to post-exercise
Time frame: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Change in percentage of lymphocytes relative to total WBC count, measured from pre- to post-exercise.
Time frame: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Change in absolute count of CD3+ T lymphocytes measured from pre- to post-exercise.
Time frame: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Change in absolute count of CD4+ helper T lymphocytes measured from pre- to post-exercise.
Time frame: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Change in absolute count of CD8+ cytotoxic T lymphocytes measured from pre- to post-exercise.
Time frame: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Change in absolute count of CD19+ B lymphocytes measured from pre- to post-exercise.
Time frame: Pre- and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Change in absolute count of CD16/56+ natural killer (NK) cells measured from pre- to post-exercise.
Time frame: Pre-exercise and post-exercise (Day 1 for Exercise Only group; Day 5 for Exercise + Rapid Weight Loss group)
Serum creatine kinase (CK) and lactic acid (LA) levels measured to assess anaerobic performance and muscle damage.
Ankara Yildirim Beyazıt University
Other
Effects of Exercise and Short-Term Rapid Weight Loss on Whole Blood Cells and Lymphocyte Subsets in Highly Trained National-Level Wrestlers: A Two-Phase Repeated-Measures Study
Acronym: EX-RWL-Lymphoc
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06501001
Behavior, Body Weight
Toledo, Spain
View Trial DetailsNCT07487090
Behavior, Body Weight
Fort Smith, Arkansas, United States
View Trial DetailsNCT05056376
Behavior, Body Weight
Baltimore, Maryland, United States
View Trial DetailsNCT05249465
Behavior, Body Weight
Stanford, California, United States
View Trial Details